While other factors failed to demonstrate independence, the correlation between the pathological grade of glioma, SATB1 expression and MGMT promoter methylation may play a role in predicting overall survival in glioma (P=0.046 and P=0.015, P=0.012, respectively, Table 2). This evidence concerns the gene MGMT and central nervous system cancer.